Insider trades
Terrance P. Coyne, CFO of Royalty Pharma RPRX, has filed 0 purchases and 37 sales on the open market. Over the past 12 months that comes to a net sale of $38.3M. The latest trade was on 05/26.
Terrance P. Coyne
EVP & CFO
- Company
- Royalty Pharma RPRX
- First filing
- 23/07/14
- Trades
- 46 trades
- Buys / sales
- 0 / 37
- 12-month net buying
- −$38.3M
- Last trade
- 05/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Royalty PharmaRPRX | Open-market sale10b5-1 plan | 05/26 | 05/28 | 64,399 sh | $53.98 | $3,476,258.02 | −100.0% |
RPRX | Open-market sale10b5-1 plan | 04/28 | 04/30 | 34,791 sh2 trades | $49.78avg. | $1,731,895.98 | −46.4% |
RPRX | Open-market sale10b5-1 plan | 04/01 | 04/02 | 34,791 sh2 trades | $48.33avg. | $1,681,449.03 | −51.4% |
RPRX | Open-market sale10b5-1 plan | 03/23 | 03/25 | 34,791 sh2 trades | $45.53avg. | $1,584,034.23 | −44.2% |
RPRX | Open-market sale10b5-1 plan | 03/02 | 03/04 | 34,791 sh4 trades | $46.78avg. | $1,627,440.05 | −43.2% |
RPRX | Open-market sale10b5-1 plan | 02/23 | 02/25 | 34,791 sh2 trades | $45.32avg. | $1,576,728.12 | −42.2% |
RPRX | Open-market sale10b5-1 plan | 02/02–02/04 | 02/04 | 243,541 sh6 trades | $42.54avg. | $10,359,967.55 | −91.4% |
RPRX | Open-market sale10b5-1 plan | 01/20 | 01/23 | 69,582 sh2 trades | $39.35avg. | $2,738,051.7 | −65.9% |
RPRX | Open-market sale10b5-1 plan | 01/02 | 01/06 | 69,582 sh2 trades | $38.42avg. | $2,673,340.44 | −63.6% |
RPRX | Open-market sale10b5-1 plan | 25/12/15 | 25/12/17 | 69,582 sh2 trades | $38.36avg. | $2,669,165.52 | −61.5% |
RPRX | Open-market sale10b5-1 plan | 25/12/01 | 25/12/03 | 69,582 sh2 trades | $39.87avg. | $2,774,234.34 | −59.6% |
RPRX | Open-market sale10b5-1 plan | 25/11/24 | 25/11/26 | 69,582 sh4 trades | $38.55avg. | $2,682,705.84 | −57.7% |
RPRX | Open-market sale10b5-1 plan | 25/11/17 | 25/11/19 | 69,594 sh2 trades | $39.30avg. | $2,735,044.2 | −56.0% |
RPRX | Open-market sale10b5-1 plan | 23/08/09–23/08/10 | 23/08/11 | 75,000 sh2 trades | $30.74avg. | $2,305,125 | −8.7% |
RPRX | Open-market sale10b5-1 plan | 23/07/12–23/07/13 | 23/07/14 | 75,000 sh2 trades | $31.00avg. | $2,325,000 | −8.0% |